Hsu CY - Search Results

1

Performance status as a prognostic surrogate in hepatocellular carcinoma: Role of albumin-bilirubin and easy-albumin-bilirubin grade.

Liao JI, Ho SY, Hou MC, Liu PH, Hsu CY, Huo TI. Liao JI, et al. Among authors: hsu cy. J Chin Med Assoc. 2024 Feb 1;87(2):156-162. doi: 10.1097/JCMA.0000000000001036. Epub 2023 Dec 12. J Chin Med Assoc. 2024. PMID: 38095597

2

Assessing liver dysfunction in cirrhosis: role of the model for end-stage liver disease and its derived systems.

Lee YH, Hsu CY, Huo TI. Lee YH, et al. Among authors: hsu cy. J Chin Med Assoc. 2013 Aug;76(8):419-24. doi: 10.1016/j.jcma.2013.04.010. Epub 2013 Jun 5. J Chin Med Assoc. 2013. PMID: 23746532 Free article. Review.

3

Albumin-bilirubin (ALBI) grade-based nomogram to predict tumor recurrence in patients with hepatocellular carcinoma.

Ho SY, Hsu CY, Liu PH, Hsia CY, Su CW, Huang YH, Hou MC, Huo TI. Ho SY, et al. Among authors: hsu cy. Eur J Surg Oncol. 2019 May;45(5):776-781. doi: 10.1016/j.ejso.2018.10.541. Epub 2018 Nov 1. Eur J Surg Oncol. 2019. PMID: 30401507

4

An Albumin-Bilirubin (ALBI) Grade-based Prognostic Model For Patients With Hepatocellular Carcinoma Within Milan Criteria.

Ho SY, Liu PH, Hsu CY, Hsia CY, Su CW, Huang YH, Lei HJ, He YJ, Hou MC, Huo TI. Ho SY, et al. Among authors: hsu cy. Am J Clin Oncol. 2019 Sep;42(9):698-704. doi: 10.1097/COC.0000000000000581. Am J Clin Oncol. 2019. PMID: 31335351

5

Albumin-bilirubin grade-based nomogram of the BCLC system for personalized prognostic prediction in hepatocellular carcinoma.

Ho SY, Hsu CY, Liu PH, Hsia CY, Lei HJ, Huang YH, Ko CC, Su CW, Lee RC, Hou MC, Huo TI. Ho SY, et al. Among authors: hsu cy. Liver Int. 2020 Jan;40(1):205-214. doi: 10.1111/liv.14249. Epub 2019 Sep 20. Liver Int. 2020. PMID: 31505104 Free article.

6

A New Prognostic Model Based on Albumin-Bilirubin Grade for Hepatocellular Carcinoma Beyond the Milan Criteria.

Ho SY, Liu PH, Hsu CY, Hsia CY, Huang YH, Su CW, Lei HJ, Lee RC, Hou MC, Huo TI. Ho SY, et al. Among authors: hsu cy. Dig Dis Sci. 2020 Feb;65(2):658-667. doi: 10.1007/s10620-019-05813-1. Epub 2019 Oct 28. Dig Dis Sci. 2020. PMID: 31659612

7

Evolution of etiology, presentation, management and prognostic tool in hepatocellular carcinoma.

Ho SY, Liu PH, Hsu CY, Hsia CY, Huang YH, Lei HJ, Su CW, Lee RC, Hou MC, Huo TI. Ho SY, et al. Among authors: hsu cy. Sci Rep. 2020 Mar 3;10(1):3925. doi: 10.1038/s41598-020-61028-9. Sci Rep. 2020. PMID: 32127619 Free PMC article.

8

Survival of Patients with Hepatocellular Carcinoma in Renal Insufficiency: Prognostic Role of Albumin-Bilirubin Grade.

Ho SY, Hsu CY, Liu PH, Ko CC, Huang YH, Su CW, Lee RC, Hou MC, Huo TI. Ho SY, et al. Among authors: hsu cy. Cancers (Basel). 2020 Apr 30;12(5):1130. doi: 10.3390/cancers12051130. Cancers (Basel). 2020. PMID: 32366000 Free PMC article.

9

Albumin-Bilirubin (ALBI) Grade-Based Nomogram for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization.

Ho SY, Hsu CY, Liu PH, Lee RC, Ko CC, Huang YH, Su CW, Hou MC, Huo TI. Ho SY, et al. Among authors: hsu cy. Dig Dis Sci. 2021 May;66(5):1730-1738. doi: 10.1007/s10620-020-06384-2. Epub 2020 Jun 16. Dig Dis Sci. 2021. PMID: 32548811

10

ALBI grade in dialysis patients with hepatocellular carcinoma: prognostic impact and staging strategy.

Ho SY, Liu PH, Hsu CY, Ko CC, Huang YH, Su CW, Hsia CY, Lee RC, Hou MC, Huo TI. Ho SY, et al. Among authors: hsu cy. J Gastrointest Oncol. 2021 Apr;12(2):722-734. doi: 10.21037/jgo-20-332. J Gastrointest Oncol. 2021. PMID: 34012661 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,044 results

Search Page

Filters